Does Critical Illness Change Levofloxacin Pharmacokinetics?

Benzer Materyaller

• We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
  Yazar:: Cotta, Menino Osbert, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
  Yazar:: Pea, Federico, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• A Systematic Review of Studies Reporting Antibiotic Pharmacokinetic Data in the Cerebrospinal Fluid of Critically Ill Patients with Uninflamed Meninges
  Yazar:: Kumta, Nilesh, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Pharmacokinetics of Levofloxacin and Ciprofloxacin during Continuous Renal Replacement Therapy in Critically Ill Patients
  Yazar:: Malone, Rebecca S., ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function
  Yazar:: Cojutti, Pier Giorgio, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)